Third win in a row for cancer researchers
Tuesday, 20 December 2011
ECU researchers have awarded further funding for their research into exercise as a treatment for prostate cancer
ECU’s Health and Wellness Research Institute have been awarded a further $450,000 for their groundbreaking work in prostate cancer research.
This latest successful grant has been funded by Cancer Australia in partnership with the Prostate Cancer Foundation of Australia (PCFA) and Beyond Blue.
The funding is the team’s third nationally competitive category 1 grant for 2011, following on from two successful funding announcements from the PCFA in November and the Australian Unity Fellowship grant in November.
The Foundation Professor of Exercise and Sports Science, Rob Newton, and the Director of ECU's Health and Wellness Institute, Associate Professor Daniel Galvão, will use the funding to further develop their research into exercise as medicine for prostate cancer.
The research team will investigate:
- If exercise at the beginning of testosterone suppression treatment will help reduce or even prevent the negative side effects of cancer treatment drugs on the body.
- If continued exercise after treatment provides additional long-term benefits.
- The clinical guidelines for the concurrent prescription of exercise for men undergoing testosterone treatment.
Professor Newton hopes the research will ultimately improve the lives of those diagnosed with prostate cancer.
“This holistic approach will result in more effective clinical guidelines for managing patients, in particular maximising uptake and increasing the longer-term use of exercise medicine,” Professor Newton said.
“In terms of advancement of prostate cancer care, we expect the knowledge gained from this project will improve physical and functional ability, quality of life and mental health, and ultimately the survival rates of men diagnosed with prostate cancer.”
In November the team received nearly $400,000 from the PCFA. This followed on from a $55,000 Australian Unity Fellowship grant to investigate the use of vibration therapy in the fight against prostate cancer.
For Associate Professor Galvão, this recent win is proof that the research coming out of the Institute is respected on a national level.
“We are delighted to receive our third category one grant for 2011 and look forward to further developing our research in the New Year.”